National Institute on Drug Abuse; Notice of Closed Meeting, 26156 [2024-07885]

Download as PDF 26156 Federal Register / Vol. 89, No. 73 / Monday, April 15, 2024 / Notices basis in accordance with the plan of care. • Section 486.525(a)(1), to provide professional services, including nursing services. • Section 486.525(a)(2), to address the requirement for patient education and training to be available for patients on a 7 day a week, 24 hour a day basis in accordance with the plan of care. • Section 486.525(a)(3), to address the requirement of remote monitoring for the provision of HIT and home infusion drugs. B. Term of Approval Based on the review and observations described in section III. of this final notice, we have determined that ACHC’s requirements for HITs meet or exceed our requirements. Therefore, we approve ACHC as a national accreditation organization for HITs that request participation in the Medicare program, effective April 23, 2024 through April 23, 2030. VI. Collection of Information Requirements This document does not impose information collection requirements, that is, reporting, recordkeeping, or third-party disclosure requirements. Consequently, there is no need for review by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35). The Administrator of the Centers for Medicare & Medicaid Services (CMS), Chiquita Brooks-LaSure, having reviewed and approved this document, authorizes Trenesha Fultz-Mimms, who is the Federal Register Liaison, to electronically sign this document for purposes of publication in the Federal Register. Trenesha Fultz-Mimms, Federal Register Liaison, Centers for Medicare & Medicaid Services. ddrumheller on DSK120RN23PROD with NOTICES1 [FR Doc. 2024–07884 Filed 4–12–24; 8:45 am] 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA REI-Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Minority Populations. Date: April 26, 2024. Time: 3:30 p.m. to 4:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Sudhirkumar U. Yanpallewar, M.D., Scientific Review Officer, Scientific Review Branch, National Institute on Drug Abuse, NIH 301 North Stonestreet Avenue, Bethesda, MD 20892, (301) 443– 4577, sudhirkumar.yanpallewar@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: April 10, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–07885 Filed 4–12–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY BILLING CODE 4120–01–P U.S. Immigration and Customs Enforcement DEPARTMENT OF HEALTH AND HUMAN SERVICES [Docket No. ICEB–2024–0005] National Institutes of Health Employment Authorization for Certain Palestinian F–1 Nonimmigrant Students Experiencing Severe Economic Hardship as a Direct Result of the Current Humanitarian Crisis in the Palestinian Territories RIN 1653–ZA49 National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections VerDate Sep<11>2014 17:44 Apr 12, 2024 Jkt 262001 U.S. Immigration and Customs Enforcement; Department of Homeland Security. ACTION: Notice. AGENCY: PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 The Department of Homeland Security (DHS) is suspending certain regulatory requirements for certain Palestinian F–1 nonimmigrant students who are experiencing severe economic hardship as a direct result of the current humanitarian crisis in the Palestinian Territories. The Secretary is providing relief to these students who are in lawful F–1 nonimmigrant status, so the students may request employment authorization, work an increased number of hours while school is in session, and reduce their course load while continuing to maintain their F–1 nonimmigrant status. DATES: This action for certain Palestinian F–1 nonimmigrant students covered by this notice began on February 14, 2024, and ends on August 13, 2025. FOR FURTHER INFORMATION CONTACT: Sharon Snyder, Unit Chief, Policy and Response Unit, Student and Exchange Visitor Program, MS 5600, U.S. Immigration and Customs Enforcement (ICE), 500 12th Street SW, Washington, DC 20536–5600; email: sevp@ ice.dhs.gov, telephone: (703) 603–3400. This is not a toll-free number. Program information can be found at https:// www.ice.gov/sevis/. SUPPLEMENTARY INFORMATION: For the purposes of this Notice, ICE intends to cover non-U.S. citizens of any nationality, or without nationality, who are Palestinian. F–1 nonimmigrant students who possesses any of the following authentic documents,1 though not limited to the list below, regardless of the document’s validity period 2 or expiration may be eligible for this relief: • a Palestinian Authority Passport; • a Palestinian Authority Identification Card; • a Birth Certificate or Birth Extract verified or issued by a recognized governmental authority identifying the holder as having been born in the Palestinian Territories; • an identification document issued by a third country, the United Nations, its specialized agencies and related organizations, or the International Committee of the Red Cross, indicating the holder is a Palestinian; or • a travel document issued by a third country, the United Nations, its SUMMARY: 1 On June 14, 2007, Hamas, designated as a foreign terrorist organization by the Secretary of State in accordance with INA section 219, took de facto administrative control of Gaza, including issuance of civil documents for the territory. Identity documents issued by Hamas after June 14, 2007, will not be accepted, unless verified by the Palestinian Authority in the West Bank. 2 The term validity period is used in reference to the length of time a document can be used for purposes of travel or identification prior to the expiration date. E:\FR\FM\15APN1.SGM 15APN1

Agencies

[Federal Register Volume 89, Number 73 (Monday, April 15, 2024)]
[Notices]
[Page 26156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07885]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA REI-Reaching Equity at the Intersection of HIV 
and Substance Use: Novel Approaches to Address HIV Related Health 
Disparities in Minority Populations.
    Date: April 26, 2024.
    Time: 3:30 p.m. to 4:15 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, (Virtual 
Meeting).
    Contact Person: Sudhirkumar U. Yanpallewar, M.D., Scientific 
Review Officer, Scientific Review Branch, National Institute on Drug 
Abuse, NIH 301 North Stonestreet Avenue, Bethesda, MD 20892, (301) 
443-4577, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: April 10, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-07885 Filed 4-12-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.